BERTOLETTI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 588
EU - Europa 376
AS - Asia 292
OC - Oceania 1
SA - Sud America 1
Totale 1.258
Nazione #
US - Stati Uniti d'America 582
CN - Cina 254
IE - Irlanda 116
FI - Finlandia 61
UA - Ucraina 59
DE - Germania 45
IT - Italia 36
SG - Singapore 33
SE - Svezia 22
GB - Regno Unito 16
BE - Belgio 10
FR - Francia 7
CA - Canada 6
IN - India 2
NO - Norvegia 2
BR - Brasile 1
IQ - Iraq 1
JP - Giappone 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 1.258
Città #
Chandler 127
Dublin 115
Jacksonville 90
Nanjing 64
Ashburn 62
Beijing 51
Ann Arbor 49
Nanchang 30
Boardman 28
Singapore 26
Helsinki 24
Pavia 24
Princeton 21
Changsha 20
Shenyang 20
Wilmington 20
Lawrence 19
Jiaxing 17
Medford 17
Hebei 15
Washington 13
Hangzhou 12
Brussels 10
Tianjin 8
Woodbridge 7
Toronto 6
Verona 5
Des Moines 4
Los Angeles 4
Milan 4
New York 4
Munich 3
Norwalk 3
San Francisco 3
Shanghai 3
Lanzhou 2
Lucino 2
Oslo 2
Auckland 1
Changchun 1
Chicago 1
Fairfield 1
Groningen 1
Jinan 1
Kirkuk 1
Lincoln 1
London 1
Manchester 1
Ningbo 1
Novokuznetsk 1
Portland 1
Pune 1
Shijiazhuang 1
São Paulo 1
Tokyo 1
Xiaogan 1
Totale 952
Nome #
Characterisation of beta2-microglobulin conformers using Ion-Exchange LC-ESI-MS 92
Characterisation by Capillary Electrophoresis of wild type and new naturally amyloidogenic variant of beta2-microglobulin 88
Beta2-microglobulin and amyloidosis: separation and characterization of protein folding conformers 87
Integrated strategies for affinity-based screening: from binding to in silico studies 79
Capillary electrophoresis analysis of different variants of the amyloidogenic protein β2 -microglobulin as a simple tool for misfolding and stability studies 75
Characterization of different variants of beta2-microglobulin by capillary electrophoresis and high-resolution mass spectrometry 73
Evaluation of capillary electrophoresis-mass spectrometry for the analysis of the conformational heterogeneity of intact proteins using beta2-microglobulin as model compound 72
A Combined High Resolution Mass Spectrometric and in Silico Approach for the Characterisation of Small Ligands of β2-microglobulin 71
Capillary electrophoresis, mass spectrometry and in silico studies: a multidisciplinary approach for drug discovery 69
Mass spectrometry and affinity capillary electrophoresis: an integrated approach for rapid screening of protein-drug binding 66
Covalent modification of beta2-microglobulin induced by reactive carbonyl species: high resolution mass spectrometric studies 63
Integrated strategies for drug discovery: capillary electrophoresis, mass spectrometry and in silico studies 62
Capillary electrophoresis in vitro separation of Abeta oligomers as drug targets: the sample preparation issue 62
Advanced glycation end products of beta2-microglobulin in uremic patients as determined by high resolution mass spectrometry 61
Prolidase deficiency may be reversed by hematopietic stem cell transplantation: CE analysis of dipeptides in urine and monitoring of prolidase activity in blood. 60
Separation and characterisation of beta2-microglobulin folding conformers by ion-exchange liquid chromatography and ion-exchange liquid chromatography-mass spectrometry 59
Optimisation of CE-ESI-MS platform for intact protein analysis: conformational studies on beta2-microglobulin. 54
Screening of Fibrillogenesis Inhibitors of β2-microglobulin: Integrated Strategies by Mass Spectrometry, Capillary Electrophoresis and in Silico Simulations 54
Screening of fibrillogenesis inhibitors of beta2-microglobulin: integrated strategie by MS, CE and docking Studies 43
Totale 1.290
Categoria #
all - tutte 4.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 0 0 0 0 0 15 2 15 1 57 14 0
2020/2021138 20 11 2 15 0 15 3 19 14 22 15 2
2021/2022131 4 2 4 3 3 9 3 3 5 1 26 68
2022/2023368 31 39 1 26 38 26 0 32 140 13 17 5
2023/2024126 6 14 13 13 13 55 1 2 0 4 0 5
2024/202574 2 23 10 14 7 18 0 0 0 0 0 0
Totale 1.290